Clinical Trial Update: COVID-19 Vaccine Response in Sickle Cell Disease

View source ↗

Summary

A completed clinical trial evaluated the immune response to a COVID-19 vaccine in people with Sickle Cell Disease; results were posted on 2025-02-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• COVID-19 vaccine (COVID-19 vaccine)

Snippet

Sponsor: ASH Research Collaborative | Conditions: Sickle Cell Disease, COVID-19 | Status: COMPLETED | Results posted: 2025-02-14